Dysregulation of the NOD2-mediated defense against enteric bacteria (e.g., pathogenic adherent-invasive E. coli) in patients with NOD2 mutations and dysfunction of mucosal hBD-2 may play an important role in the pathogenesis of IBD [66,89,90]. The gene discussed is NOD2; the disease is inflammatory bowel disease.